Enwei Pharmaceutical Co., Ltd. (SHE:301331)
25.91
+0.12 (0.47%)
At close: May 9, 2025, 2:57 PM CST
Enwei Pharmaceutical Market Cap
Enwei Pharmaceutical has a market cap or net worth of 2.64 billion as of May 12, 2025. Its market cap has increased by 0.62% in one year.
Market Cap
2.64B
Enterprise Value
2.31B
Revenue
825.15M
Ranking
n/a
PE Ratio
57.80
Stock Price
25.91
Market Cap Chart
Since September 21, 2022, Enwei Pharmaceutical's market cap has decreased from 3.07B to 2.64B, a decrease of -13.99%. That is a compound annual growth rate of -5.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 2.62B | 13.51% |
Dec 31, 2024 | 2.31B | -20.75% |
Dec 29, 2023 | 2.91B | 4.40% |
Dec 30, 2022 | 2.79B | -9.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 335.80B |
Shenzhen Mindray Bio-Medical Electronics | 270.90B |
WuXi AppTec | 168.36B |
Zhangzhou Pientzehuang Pharmaceutical., | 125.22B |
Aier Eye Hospital Group | 119.56B |
Sichuan Biokin Pharmaceutical | 112.28B |
Shanghai United Imaging Healthcare | 112.08B |
Yunnan Baiyao Group Co.,Ltd | 101.81B |